Votorantim 3Q Financial Results

Votorantim Disclaimer The information contained in this presentation concerning Votorantim Industrial S.A. and its subsidiaries ("Votorantim") may be deemed to include statements which constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a certain degree of risk and uncertainty with respect to Votorantim's business, financial information, trend, strategy and other projections, and are based on assumptions, data or methods which, although considered reasonable by Votorantim at the time, may turn out to be incorrect or imprecise, or may not be possible to attain, or may differ materially from actual results, due to a variety of factors. Votorantim cannot guarantee that any forward-looking statements or expectations disclosed in this presentation will prove to be correct and does not undertake, and specifically disclaims any obligation to update any forward-looking statements or any other information, which speak only for the date they are made. The market and competitive position data, including market forecasts, used throughout or referred to in this presentation were obtained from internal surveys, market research, publicly available information and industry publications. Although Votorantim has no reason to believe that any of this information or these reports are inaccurate in any material respect, Votorantim has not independently verified the competitive position, market share, market size, market growth or other data provided by third parties or by industry or other publications and therefore does not make any representation as to the accuracy of any such information. This presentation and its contents are proprietary information and may not be reproduced or otherwise disseminated in whole or in part without Votorantim's prior written consent. 2

View entire presentation